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(best) scale; Pain, Symptoms, Activities of Daily Living (ADL), Sport and
Recreational activities (Sport/Rec) and Quality of Life (QOL). The PASS
anchor question was: “Considering your knee function, do you feel that
your current state is satisfactory? With knee function you should take
into account all activities during your daily life, sport and recreational
activities, your level of pain and other symptoms, and also your knee
related quality of life.” The TF anchor question was: “Would you con-
sider your current state as being so unsatisfactory that you think the
treatment has failed?”. Both questions were answered “Yes” or “No”.
The patients that answered “Yes” to the PASS question were considered
to have reached a PASS. The subgroup of patients that answered “No” to
the PASS question and “Yes” to the TF question were considered to be
treatment failures. The remaining patients were considered to be
neither.
Results: 744 patients (45% women, mean age 28.7) responded: 246
(62%) at 6 months, 261 (65.3%) at 12 months and 237 (59.3%) at 24
months postoperatively. Figure 1 presents the percentages of patients
reaching PASS and TF for each follow-up time point respectively. For all
time points, 55–66% of patients undergoing an ACLR considered
themselves to have reached a PASS postoperatively. 6–10% of the
patients considered the treatment to have failed.
Mean KOOS scores at the three follow-up time-points for the patients
reaching PASS ranged from 88–91 for the subscale Pain, 82–85 for
Symptoms, 94–96 for the subscale ADL, 69–77 for the subscale Sport/
Rec and 72–76 for the subscale QOL. The patients that considered that
the treatment had failed had worse mean KOOS scores (Pain 57–58,
Symptoms 54–57, ADL 69–73, Sport/Rec 26–32, QOL 25–31). The
patients that did not consider their symptoms state acceptable, but not
severe enough to consider themselves treatment failures, had mean
KOOS scores in between the groups achieving PASS and TF (Pain 74–81,
Symptoms 70–75, ADL 82–89, Sport/Rec 49–59 and QOL 51–57).
Conclusions: Half of the patients at six months and about two-thirds at
1–2 years consider themselves to have achieved an acceptable symp-
tom state after receiving a primary ACLR. Mean KOOS scores were
reﬂective of patient’s perception about treatment outcome after ACLR.
Patients achieving an acceptable symptom state had KOOS scores cor-
responding to on average no to mild problems while for treatment
failures the KOOS scores corresponded to on average moderate to
severe problems.
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THE ASSOCIATION BETWEEN HIP EFFUSION AND CLINICAL, MRI AND
RADIOLOGICAL FINDINGS
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Purpose: The aim of this cross-sectional study was to describe the
associations between hip effusion, hip pain, MRI-detected abnormal-
ities and radiological hip osteoarthritis (ROA).Methods: A total of 244 subjects from the Tasmanian Older Adult
Cohort [TASOAC] with a right hip STIR-weighted MRI were included in
this study. Presence and size of hip effusion was assessed at either the
anterior or posterior side of the femoral head using OsiriX imaging
software. The observer manually selected the MR slice (sagittal) with
the largest effusion and measured the maximum cross-sectional area
(CSA). Hip pain was determined by WOMAC [Western Ontario and
McMaster Universities Osteoarthritis Index]. Presence of cartilage
defects; hip BMLs and high cartilage signal were assessed. Finally, joint
space narrowing (JSN, 0–3) and osteophytes (0–3) were assessed on X-
ray using Altman’s atlas. Log binomial regression and linear regression
were applied to examine the relationships between hip effusion, hip
pain, MRI and radiological ﬁndings.
Results: 228 [93%] subjects had hip effusion [presumably physiological
and/or pathological] located, either at anterior or posterior sides of the
femoral head. Subjects without and with hip effusion had no statistical
differences in mean age and sex but subjects with hip effusion were
heavier [BMI: 26.1 v 27.9, p ¼ 0.04] in comparison to those without hip
effusion. Hip effusion did not associate with presence or severity of hip
pain. Larger hip effusion size was associated with presence of femoral
defects, especially full thickness femoral defects [mean ratio: 1.34 95%CI
1.03,1.65]. Acetabular defects did not associate with hip effusion. On the
other hand, anterior hip effusion but not other sites, associated with
presence of high cartilage signal [PR: 1.20 95%CI 1.01, 1.43]. Surprisingly,
BMLs were associated with a signiﬁcantly lower prevalence of effusion.
Overall, radiological hip OA [grade>3] was associated with 8–10%
higher prevalence of hip effusion and joint space narrowing [grade 3]
was associated with higher prevalence of hip effusion [PR: 1.10 95%CI
1.04, 1.16].
Conclusion: Hip effusion is asymptomatic in this cohort but is asso-
ciated with hip cartilage defects, JSN and osteophytes.
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OBESITY IS ASSOCIATED WITH REDUCED DISC HEIGHT IN THE
LUMBER SPINE BUT NOT AT THE LUMBOSACRAL JUNCTION
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Purpose: Although obesity is a recognised risk factor for low back pain,
our understanding of the mechanisms for this is limited. The evidence
for an association between obesity and spinal structural changes is also
conﬂicting. The aim of this study was to investigate the relationships
between obesity, disc height and low back pain in the lumbosacral
spine.
Methods: 72 participants from a community-based study of muscu-
loskeletal health underwent Magnetic Resonance Imaging from the T12
vertebral body to the sacrum. Disc height was measured from L1/2 to
L5/S1. Body mass index was measured and low back pain in the pre-
vious 2 weeks was assessed.
Results: The mean and total lumbar disc heights were reduced in obese
compared to non-obese individuals (mean height(SE): 1.04(0.03)cm vs
1.14(0.02)cm, p ¼ 0.01; total height(SE): 4.16(0.11)cm vs 4.57(0.10)cm, p
¼ 0.01), after adjusting for age, gender and height. While obesity was
associated with reduced disc heights at the L1/2 and L3/4 levels, there
were no signiﬁcant relationship at the lumbosacral junction (mean
difference (95%CI): 0.10(0.14, 0.16)cm, p ¼ 0.89). Both mean and total
lumbar disc heights were negatively associated with recent pain after
adjusting for age, gender and height (mean height: mean difference
(95%CI): 0.09(0.02, 0.17)cm, p¼ 0.02; total height: mean difference (95%
CI): 0.37(0.07,0.66)cm, p ¼ 0.02). However, these relationships were no
longer signiﬁcant when we also adjusted for weight (mean height;
mean difference (95%CI): 0.07(0.009,0.15)cm, p ¼ 0.08; total height:
mean difference (95%CI): 0.28(0.04, 0.60)cm, p ¼ 0.08). There were no
signiﬁcant relationships between disc height and recent pain at the
lumbosacral junction.
Conclusions: Obesity was associated with reduced disc height in the
lumbar spine, but not at the lumbosacral junction, suggesting these
joints may have different risk factors. There was also evidence for an
inter-relationship between obesity, lumbar disc height and recent pain,
suggesting that structural changes have a role in back pain and may in
part explain the association between obesity and back pain.
